Cargando…
Microencapsulated foods as a functional delivery vehicle for omega-3 fatty acids: a pilot study
It is well established that the ingestion of the omega-3 (N3) fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) positively benefit a variety of health indices. Despite these benefits the actual intake of fish derived N3 is relatively small in the United States. The primary aim o...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694142/ https://www.ncbi.nlm.nih.gov/pubmed/19480650 http://dx.doi.org/10.1186/1550-2783-6-12 |
_version_ | 1782168041396633600 |
---|---|
author | Earnest, Conrad P Hammar, Molly K Munsey, Monica Mikus, Catherine R David, Robert M Bralley, J Alexander Church, Timothy S |
author_facet | Earnest, Conrad P Hammar, Molly K Munsey, Monica Mikus, Catherine R David, Robert M Bralley, J Alexander Church, Timothy S |
author_sort | Earnest, Conrad P |
collection | PubMed |
description | It is well established that the ingestion of the omega-3 (N3) fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) positively benefit a variety of health indices. Despite these benefits the actual intake of fish derived N3 is relatively small in the United States. The primary aim of our study was to examine a technology capable of delivering omega-3 fatty acids in common foods via microencapsulation (MicroN3) in young, healthy, active participants who are at low risk for cardiovascular disease. Accordingly, we randomized 20 participants (25.4 ± 6.2 y; 73.4 ± 5.1 kg) to receive the double blind delivery of a placebo-matched breakfast meal (~2093 kJ) containing MicroN3 (450–550 mg EPA/DHA) during a 2-week pilot trial. Overall, we observed no differences in overall dietary macronutrient intake other than the N3 delivery during our treatment regimen. Post-test ANOVA analysis showed a significant elevation in mean (SE) plasma DHA (91.18 ± 9.3 vs. 125.58 ± 11.3 umol/L; P < 0.05) and a reduction in triacylglycerols (89.89 ± 12.8 vs. 80.78 ± 10.4 mg/dL; P < 0.05) accompanying the MicroN3 treatment that was significantly different from placebo (P < 0.05). In post study interviews, participants reported that the ingested food was well-tolerated, contained no fish taste, odor or gastrointestinal distress accompanying treatment. The use of MicroN3 foods provides a novel delivery system for the delivery of essential fatty acids. Our study demonstrates that MicroN3 foods promote the absorption of essential N3, demonstrate bioactivity within 2 weeks of ingestion and are well tolerated in young, active participants who are at low risk for cardiovascular disease. |
format | Text |
id | pubmed-2694142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26941422009-06-09 Microencapsulated foods as a functional delivery vehicle for omega-3 fatty acids: a pilot study Earnest, Conrad P Hammar, Molly K Munsey, Monica Mikus, Catherine R David, Robert M Bralley, J Alexander Church, Timothy S J Int Soc Sports Nutr Short Reports It is well established that the ingestion of the omega-3 (N3) fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) positively benefit a variety of health indices. Despite these benefits the actual intake of fish derived N3 is relatively small in the United States. The primary aim of our study was to examine a technology capable of delivering omega-3 fatty acids in common foods via microencapsulation (MicroN3) in young, healthy, active participants who are at low risk for cardiovascular disease. Accordingly, we randomized 20 participants (25.4 ± 6.2 y; 73.4 ± 5.1 kg) to receive the double blind delivery of a placebo-matched breakfast meal (~2093 kJ) containing MicroN3 (450–550 mg EPA/DHA) during a 2-week pilot trial. Overall, we observed no differences in overall dietary macronutrient intake other than the N3 delivery during our treatment regimen. Post-test ANOVA analysis showed a significant elevation in mean (SE) plasma DHA (91.18 ± 9.3 vs. 125.58 ± 11.3 umol/L; P < 0.05) and a reduction in triacylglycerols (89.89 ± 12.8 vs. 80.78 ± 10.4 mg/dL; P < 0.05) accompanying the MicroN3 treatment that was significantly different from placebo (P < 0.05). In post study interviews, participants reported that the ingested food was well-tolerated, contained no fish taste, odor or gastrointestinal distress accompanying treatment. The use of MicroN3 foods provides a novel delivery system for the delivery of essential fatty acids. Our study demonstrates that MicroN3 foods promote the absorption of essential N3, demonstrate bioactivity within 2 weeks of ingestion and are well tolerated in young, active participants who are at low risk for cardiovascular disease. BioMed Central 2009-05-29 /pmc/articles/PMC2694142/ /pubmed/19480650 http://dx.doi.org/10.1186/1550-2783-6-12 Text en Copyright © 2009 Earnest et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Reports Earnest, Conrad P Hammar, Molly K Munsey, Monica Mikus, Catherine R David, Robert M Bralley, J Alexander Church, Timothy S Microencapsulated foods as a functional delivery vehicle for omega-3 fatty acids: a pilot study |
title | Microencapsulated foods as a functional delivery vehicle for omega-3 fatty acids: a pilot study |
title_full | Microencapsulated foods as a functional delivery vehicle for omega-3 fatty acids: a pilot study |
title_fullStr | Microencapsulated foods as a functional delivery vehicle for omega-3 fatty acids: a pilot study |
title_full_unstemmed | Microencapsulated foods as a functional delivery vehicle for omega-3 fatty acids: a pilot study |
title_short | Microencapsulated foods as a functional delivery vehicle for omega-3 fatty acids: a pilot study |
title_sort | microencapsulated foods as a functional delivery vehicle for omega-3 fatty acids: a pilot study |
topic | Short Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694142/ https://www.ncbi.nlm.nih.gov/pubmed/19480650 http://dx.doi.org/10.1186/1550-2783-6-12 |
work_keys_str_mv | AT earnestconradp microencapsulatedfoodsasafunctionaldeliveryvehicleforomega3fattyacidsapilotstudy AT hammarmollyk microencapsulatedfoodsasafunctionaldeliveryvehicleforomega3fattyacidsapilotstudy AT munseymonica microencapsulatedfoodsasafunctionaldeliveryvehicleforomega3fattyacidsapilotstudy AT mikuscatheriner microencapsulatedfoodsasafunctionaldeliveryvehicleforomega3fattyacidsapilotstudy AT davidrobertm microencapsulatedfoodsasafunctionaldeliveryvehicleforomega3fattyacidsapilotstudy AT bralleyjalexander microencapsulatedfoodsasafunctionaldeliveryvehicleforomega3fattyacidsapilotstudy AT churchtimothys microencapsulatedfoodsasafunctionaldeliveryvehicleforomega3fattyacidsapilotstudy |